Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swander Pace Capital is a leading private equity firm specializing in strategic investments in middle-market consumer products companies, with a significant focus on the consumer healthcare sector. Since its inception in 1996, the firm has partnered with companies in the over-the-counter (OTC) medication, vitamins, minerals, and supplements (VMS), and medical nutrition industries. SPC provides more than just capital, offering deep functional expertise in areas such as brand strategy, product innovation, and supply chain management. Their healthcare portfolio has included notable names such as Captek Softgel International, a leading contract manufacturer, and Functional Formularies, a provider of whole-food enteral nutrition. The firm operates out of offices in San Francisco, New Jersey, and Toronto, targeting businesses with revenues typically between $20 million and $500 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swander Pace Capital.